An Updated Critical Analysis of the Treatment Strategy for Newly Diagnosed High-grade T1 (Previously T1G3) Bladder Cancer
- 31 January 2010
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 57 (1), 60-70
- https://doi.org/10.1016/j.eururo.2009.08.024
Abstract
No abstract availableThis publication has 86 references indexed in Scilit:
- Low-Dose Instillation Therapy with Bacille Calmette-Guérin Tokyo 172 Strain After Transurethral Resection: Historical Cohort StudyUrology, 2008
- Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational studyBritish Journal of Cancer, 2007
- Optimal Management of High-Risk T1G3 Bladder Cancer: A Decision AnalysisPLoS Medicine, 2007
- A re‐staging transurethral resection predicts early progression of superficial bladder cancerBJU International, 2006
- The value of a second transurethral resection for T1 bladder cancerBJU International, 2006
- Is a Second Transurethral Resection Necessary for Newly Diagnosed pT1 Bladder Cancer?Journal of Urology, 2006
- A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?European Urology, 2004
- The Value of a Second Transurethral Resection in Evaluating Patients with Bladder TumoursEuropean Urology, 2003
- SECOND RESECTION AND PROGNOSIS OF PRIMARY HIGH RISK SUPERFICIAL BLADDER CANCER: IS CYSTECTOMY OFTEN TOO EARLY?Journal of Urology, 2001
- THE VALUE OF A SECOND TRANSURETHRAL RESECTION IN EVALUATING PATIENTS WITH BLADDER TUMORSJournal of Urology, 1999